CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

AN2 rises after early-stage trial data for Chagas disease therapy

Phase 1positivePositive
AI Analysis

Summary

Anaptys Bio (AN2) reported positive early-stage trial data for a Chagas disease therapy candidate, resulting in stock price appreciation.

Clinical Trial Data

Phase

1

Importance:5/10
Sentiment:
0.70
clinical_trialphase_1_datachagas_diseasestock_movement
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on June 4, 2026 12:21 PM

Read Original